BJA Advance Access originally published online on January 16, 2007
British Journal of Anaesthesia 2007 98(3):317-322; doi:10.1093/bja/ael366
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Predictive value of IL-18 and SC5b-9 for neurocognitive dysfunction after cardiopulmonary bypass
Department of Anaesthetics and Intensive Care Medicine, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK
* Corresponding author: Department of Anaesthetics and Intensive Care Medicine, Wales College of Medicine, Cardiff University, Heath Park, Cardiff CF14 4XN, UK. E-mail: arunkumar{at}btinternet.com
BACKGROUND: Neurological injury after cardiopulmonary bypass (CPB) continues to be a major problem after cardiac surgery. The aim of this study was to investigate the predictive value of Interleukin-18 (IL-18) and SC5b-9 as biochemical markers of neurocognitive dysfunction after cardiac surgery.
METHODS: A total of 30 patients undergoing elective cardiac surgery using CPB were recruited. Blood samples were obtained for IL-18 and SC5b-9 concentrations before induction, 24, 48, 72, 96 and 120 h post-CPB and 6 weeks after operation. In addition, patients underwent a standard battery of neuropsychometric tests before operation and at day 5 and 6 weeks after operation.
RESULTS: Serum concentration of IL-18, but not SC5b-9, was significantly different between patients with and without neurocognitive dysfunction; serum IL-18 concentration significantly increased in patients with neurocognitive dysfunction (P = 0.018). Neurological outcome was significantly dependent on peak difference in IL-18 concentration at day 5 (P = 0.033), but not on peak difference in SC5b-9 concentration (P = 0.16). Eight patients had neurocognitive dysfunction at day 5 and three had neurocognitive dysfunction at 6 weeks. In a very small number of patients, no significant association was demonstrated between IL-18 or SC5b-9 concentrations and neurocognitive dysfunction at 6 weeks.
CONCLUSIONS: IL-18 has the potential as a useful marker of neurological dysfunction, requiring further investigation.
Keywords: blood, IL-18; blood, SC5b-9; brain, injury; heart, cardiopulmonary bypass; polypeptides, IL-18; polypeptides, SC5b-9
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. P. Alston, R. A. Kumar, C. Cann, J. Hall, P. Sudheer, and A. Wilkes IL-18 and SC5b-9 for predicting neurocognitive dysfunction after cardiopulmonary bypass Br. J. Anaesth., September 1, 2007; 99(3): 444 - 445. [Full Text] [PDF] |
||||
E-letters:
Read all E-letters
- The perils of dichotomisation
- R Peter Alston
- British Journal of Anaesthesia, 11 May 2007 [Full text]
- IL-18 and SC5b-9 for predicting neurocognitive dysfunction after cardiopulmonary bypass
- Rajappan-Nair A Kumar, et al.
- British Journal of Anaesthesia, 6 Jun 2007 [Full text]
